| Author | Title | Year | Journal/Proceedings | Reftype | DOI/URL |
|---|---|---|---|---|---|
| Adams, J. D., Klaidman, L. K., Odunze, I. N., Shen, H. C. & Miller, C. A. | Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. | 1991 | Mol Chem Neuropathol | article | URL |
| Andersen, J. K. | Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease? | 2001 | Novartis Found Symp | article | URL |
| Arosio, E., Marchi, S. D., Zannoni, M., Prior, M. & Lechi, A. | Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. | 2002 | Mayo Clin Proc | article | URL |
| Bannon, M. J., Goedert, M. & Williams, B. | The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease. | 1984 | Biochem Pharmacol | article | URL |
| Berent-Spillson, A. & Russell, J. W. | Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. | 2007 | J Neurochem | article | DOIURL |
| Bharat, S., Cochran, B. C., Hsu, M., Liu, J., Ames, B. N. & Andersen, J. K. | Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. | 2002 | Neurotoxicology | article | URL |
| Bharath, S. & Andersen, J. K. | Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. | 2005 | Antioxid Redox Signal | article | DOIURL |
| Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S. & Andersen, J. K. | Glutathione, iron and Parkinson's disease. | 2002 | Biochem Pharmacol | article | URL |
| Bravenboer, B., Kappelle, A. C., Hamers, F. P., van Buren, T., Erkelens, D. W. & Gispen, W. H. | Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. | 1992 | Diabetologia | article | URL |
| Canals, S., Casarejos, M. J., de Bernardo, S., Rodríguez-Martín, E. & Mena, M. A. | Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease. | 2001 | J Neurochem | article | URL |
| Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E. & Catalano, G. | Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. | 2002 | J Clin Oncol | article | URL |
| Cascinu, S., Cordella, L., Ferro, E. D., Fronzoni, M. & Catalano, G. | Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. | 1995 | J Clin Oncol | article | URL |
| Chinta, S. J. & Andersen, J. K. | Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. | 2006 | Free Radic Biol Med | article | DOIURL |
| Coppola, L., Grassia, A., Giunta, R., Verrazzo, G., Cava, B., Tirelli, A. & D'Onofrio, F. | Glutathione (GSH) improved haemostatic and haemorheological parameters in atherosclerotic subjects. | 1992 | Drugs Exp Clin Res | article | URL |
| Costagliola, C., Cotticelli, L., Menzione, M., Rinaldi, M., Russo, S. & Rinaldi, E. | Red cell reduced glutathione and tobacco smoke-induced optic neuropathy. | 1990 | Metab Pediatr Syst Ophthalmol | article | URL |
| Costagliola, C., Romano, L., Scibelli, G., de Vincentiis, A., Sorice, P. & Benedetto, A. D. | Anemia and chronic renal failure: a therapeutical approach by reduced glutathione parenteral administration. | 1992 | Nephron | article | URL |
| van Dam, P. S., van Asbeck, B. S., Oirschot, J. F. V., Biessels, G. J., Hamers, F. P. & Marx, J. J. | Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state. | 2001 | Eur J Clin Invest | article | URL |
| Drukarch, B., Jongenelen, C. A., Schepens, E., Langeveld, C. H. & Stoof, J. C. | Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease. | 1996 | J Neurosci | article | URL |
| Ebadi, M., Srinivasan, S. K. & Baxi, M. D. | Oxidative stress and antioxidant therapy in Parkinson's disease. | 1996 | Prog Neurobiol | article | URL |
| Ehrhart, J. & Zeevalk, G. D. | Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures. | 2003 | J Neurochem | article | URL |
| Fitzmaurice, P. S., Ang, L., Guttman, M., Rajput, A. H., Furukawa, Y. & Kish, S. J. | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. | 2003 | Mov Disord | article | DOIURL |
| Grothey, A. | Clinical management of oxaliplatin-associated neurotoxicity. | 2005 | Clin Colorectal Cancer | article | URL |
| Gu, M., Owen, A. D., Toffa, S. E., Cooper, J. M., Dexter, D. T., Jenner, P., Marsden, C. D. & Schapira, A. H. | Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. | 1998 | J Neurol Sci | article | URL |
| Hamers, F. P., Brakkee, J. H., Cavalletti, E., Tedeschi, M., Marmonti, L., Pezzoni, G., Neijt, J. P. & Gispen, W. H. | Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. | 1993 | Cancer Res | article | URL |
| Han, J., Cheng, F. C., Yang, Z. & Dryhurst, G. | Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. | 1999 | J Neurochem | article | URL |
| Head, K. A. | Peripheral neuropathy: pathogenic mechanisms and alternative therapies. | 2006 | Altern Med Rev | article | URL |
| Hirrlinger, J., Schulz, J. B. & Dringen, R. | Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. | 2002 | J Neurochem | article | URL |
| Hong, L., Wu, J. & Cai, W. | Glutathione decreased parenteral nutrition-induced hepatocyte injury in infant rabbits. | 2007 | JPEN J Parenter Enteral Nutr | article | URL |
| Hsu, M., Srinivas, B., Kumar, J., Subramanian, R. & Andersen, J. | Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease. | 2005 | J Neurochem | article | DOIURL |
| Jenner, P. | Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. | 1993 | Acta Neurol Scand Suppl | article | URL |
| Jha, N., Jurma, O., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R. M., Forman, H. J. & Andersen, J. K. | Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. | 2000 | J Biol Chem | article | DOIURL |
| Jha, N., Kumar, M. J., Boonplueang, R. & Andersen, J. K. | Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease? | 2002 | J Neurochem | article | URL |
| Johannsen, P., Velander, G., Mai, J., Thorling, E. B. & Dupont, E. | Glutathione peroxidase in early and advanced Parkinson's disease. | 1991 | J Neurol Neurosurg Psychiatry | article | URL |
| Jurma, O. P., Hom, D. G. & Andersen, J. K. | Decreased glutathione results in calcium-mediated cell death in PC12. | 1997 | Free Radic Biol Med | article | URL |
| Kish, S. J., Morito, C. & Hornykiewicz, O. | Glutathione peroxidase activity in Parkinson's disease brain. | 1985 | Neurosci Lett | article | URL |
| Konings, C. H., Kuiper, M. A., Teerlink, T., Mulder, C., Scheltens, P. & Wolters, E. C. | Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy. | 1999 | J Neurol Sci | article | URL |
| Kooncumchoo, P., Sharma, S., Porter, J., Govitrapong, P. & Ebadi, M. | Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. | 2006 | J Mol Neurosci | article | URL |
| Lang, A. E. | The progression of Parkinson disease: a hypothesis. | 2007 | Neurology | article | DOIURL |
| Li, Y., Oliveira, S. A., Xu, P., Martin, E. R., Stenger, J. E., Scherzer, C. R., Hauser, M. A., Scott, W. K., Small, G. W., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Goetz, C. G., Mastaglia, F., Middleton, L. T., Roses, A. D., Saunders, A. M., Schmechel, D. E., Gullans, S. R., Haines, J. L., Gilbert, J. R., Vance, J. M., Pericak-Vance, M. A., Hulette, C. & Welsh-Bohmer, K. A. | Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. | 2003 | Hum Mol Genet | article | DOIURL |
| Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Havaich, M. K. & LeWitt, P. A. | Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation. | 1994 | Clin Neuropharmacol | article | URL |
| Marshall, K. A., Reist, M., Jenner, P. & Halliwell, B. | The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease. | 1999 | Free Radic Biol Med | article | URL |
| Mattia, G. D., Bravi, M. C., Laurenti, O., Cassone-Faldetta, M., Armiento, A., Ferri, C. & Balsano, F. | Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. | 1998 | Metabolism | article | URL |
| Melhem, A., Stern, M., Shibolet, O., Israeli, E., Ackerman, Z., Pappo, O., Hemed, N., Rowe, M., Ohana, H., Zabrecky, G., Cohen, R. & Ilan, Y. | Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. | 2005 | J Clin Gastroenterol | article | URL |
| Mena, S., Benlloch, M., Ortega, A., Carretero, J., Obrador, E., Asensi, M., Petschen, I., Brown, B. D. & Estrela, J. M. | Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. | 2007 | Clin Cancer Res | article | DOIURL |
| Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saillé, C. & Ceballos-Picot, I. | Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. | 1998 | Biochem Pharmacol | article | URL |
| Mizuno, Y., Mori, H. & Kondo, T. | Parkinson's disease: from etiology to treatment. | 1995 | Intern Med | article | URL |
| Monte, D. A. D., Chan, P. & Sandy, M. S. | Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? | 1992 | Ann Neurol | article | URL |
| Muran, P. J. | Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review. | 2006 | Altern Ther Health Med | article | URL |
| Nakamura, K., Wright, D. A., Wiatr, T., Kowlessur, D., Milstien, S., Lei, X. G. & Kang, U. J. | Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. | 2000 | J Neurochem | article | URL |
| Núñez, M. T., Gallardo, V., Muñoz, P., Tapia, V., Esparza, A., Salazar, J. & Speisky, H. | Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells. | 2004 | Free Radic Biol Med | article | DOIURL |
| Offen, D., Ziv, I., Sternin, H., Melamed, E. & Hochman, A. | Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. | 1996 | Exp Neurol | article | DOIURL |
| Ortolani, O., Conti, A., Gaudio, A. R. D., Moraldi, E., Cantini, Q. & Novelli, G. | The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. | 2000 | Am J Respir Crit Care Med | article | URL |
| Ortolani, O., Gratino, F., Leone, D., Russo, F. & Tufano, R. | [Usefulness of the prevention of oxygen radical damage in the critical patient using the parenteral administration of reduced glutathione in high doses] | 1992 | Boll Soc Ital Biol Sper | article | URL |
| Packer, L., Tritschler, H. J. & Wessel, K. | Neuroprotection by the metabolic antioxidant alpha-lipoic acid. | 1997 | Free Radic Biol Med | article | URL |
| Pearce, R. K., Owen, A., Daniel, S., Jenner, P. & Marsden, C. D. | Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. | 1997 | J Neural Transm | article | URL |
| Perry, T. L., Godin, D. V. & Hansen, S. | Parkinson's disease: a disorder due to nigral glutathione deficiency? | 1982 | Neurosci Lett | article | URL |
| Perry, T. L. & Yong, V. W. | Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. | 1986 | Neurosci Lett | article | URL |
| Pirovano, C., Balzarini, A., Böhm, S., Oriana, S., Spatti, G. B. & Zunino, F. | Peripheral neurotoxicity following high-dose cisplatin with glutathione: clinical and neurophysiological assessment. | 1992 | Tumori | article | URL |
| Plaxe, S., Freddo, J., Kim, S., Kirmani, S., McClay, E., Christen, R., Braly, P. & Howell, S. | Phase I trial of cisplatin in combination with glutathione. | 1994 | Gynecol Oncol | article | DOIURL |
| Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K. & Youdim, M. B. | Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. | 1989 | J Neurochem | article | URL |
| Schulz, J. B., Lindenau, J., Seyfried, J. & Dichgans, J. | Glutathione, oxidative stress and neurodegeneration. | 2000 | Eur J Biochem | article | URL |
| Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M. & Rosati, G. | Reduced intravenous glutathione in the treatment of early Parkinson's disease. | 1996 | Prog Neuropsychopharmacol Biol Psychiatry | article | URL |
| Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P. & Marsden, C. D. | Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. | 1994 | Ann Neurol | article | DOIURL |
| Sofic, E., Lange, K. W., Jellinger, K. & Riederer, P. | Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. | 1992 | Neurosci Lett | article | URL |
| Spencer, J. P., Jenner, P. & Halliwell, B. | Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease. | 1995 | Neuroreport | article | URL |
| Spina, M. B. & Cohen, G. | Dopamine turnover and glutathione oxidation: implications for Parkinson disease. | 1989 | Proc Natl Acad Sci U S A | article | URL |
| Stillman, M. & Cata, J. P. | Management of chemotherapy-induced peripheral neuropathy. | 2006 | Curr Pain Headache Rep | article | URL |
| Thornalley, P. J., McLellan, A. C., Lo, T. W., Benn, J. & Sönksen, P. H. | Negative association between erythrocyte reduced glutathione concentration and diabetic complications. | 1996 | Clin Sci (Lond) | article | URL |
| Tohgi, H., Abe, T., Saheki, M., Hamato, F., Sasaki, K. & Takahashi, S. | Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment. | 1995 | Neurosci Lett | article | URL |
| Tredici, G., Cavaletti, G., Petruccioli, M. G., Fabbrica, D., Tedeschi, M. & Venturino, P. | Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats. | 1994 | Neurotoxicology | article | URL |
| Ueno, Y., Kizaki, M., Nakagiri, R., Kamiya, T., Sumi, H. & Osawa, T. | Dietary glutathione protects rats from diabetic nephropathy and neuropathy. | 2002 | J Nutr | article | URL |
| Weber, C. A. & Ernst, M. E. | Antioxidants, supplements, and Parkinson's disease. | 2006 | Ann Pharmacother | article | DOIURL |
| Whitworth, A. J., Theodore, D. A., Greene, J. C., Benes, H., Wes, P. D. & Pallanck, L. J. | Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. | 2005 | Proc Natl Acad Sci U S A | article | DOIURL |
| Yamamoto, N., Sawada, H., Izumi, Y., Kume, T., Katsuki, H., Shimohama, S. & Akaike, A. | Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. | 2007 | J Biol Chem | article | DOIURL |
| Yantiri, F., Gasparyan, A. & Andersen, J. K. | Glutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes. | 2001 | J Neurosci Res | article | URL |
| Zeevalk, G. D., Manzino, L., Sonsalla, P. K. & Bernard, L. P. | Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease. | 2007 | Exp Neurol | article | DOIURL |
| Zhu, B., Li, X., Zhao, Q. & Huang, X. | [Enhancement of antioxidant capability of cancer patients during chemotherapy by reduced glutathione] | 2004 | Ai Zheng | article | URL |
Created by JabRef on 05/12/2007.